Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy
NCT00246610
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
Nelfinavir mesylate, 625 mg
Sponsor
Pfizer